FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.6  |  FHIR Version n/a  User: [n/a]

732936001: Tablet (unit of presentation)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jul 2017. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3498396015 Tablet (unit of presentation) en Fully specified name Active Entire term case insensitive SNOMED CT core module
3498397012 Tablet en Synonym Active Entire term case insensitive SNOMED CT core module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Tablet Is a Unit of presentation true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing precisely quinagolide 25 microgram/1 each conventional release oral tablet Has presentation strength denominator unit False Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely apalutamide 60 milligram/1 each conventional release oral tablet Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely diltiazem hydrochloride 120 milligram/1 each prolonged-release oral tablet Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely diltiazem hydrochloride 120 milligram/1 each prolonged-release oral tablet Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely cefaclor (as cefaclor monohydrate) 375 milligram/1 each prolonged-release oral tablet Has unit of presentation False Tablet Inferred relationship Existential restriction modifier
Product containing precisely cefaclor (as cefaclor monohydrate) 375 milligram/1 each prolonged-release oral tablet Has presentation strength denominator unit False Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely disopyramide (as disopyramide phosphate) 250 milligram/1 each prolonged-release oral tablet Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely disopyramide (as disopyramide phosphate) 250 milligram/1 each prolonged-release oral tablet Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely clarithromycin 500 milligram/1 each prolonged-release oral tablet Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely clarithromycin 500 milligram/1 each prolonged-release oral tablet Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely carbidopa (as carbidopa monohydrate) 25 milligram and levodopa 100 milligram/1 each prolonged-release oral tablet Has unit of presentation False Tablet Inferred relationship Existential restriction modifier
Product containing precisely carbidopa (as carbidopa monohydrate) 25 milligram and levodopa 100 milligram/1 each prolonged-release oral tablet Has presentation strength denominator unit False Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely carbidopa (as carbidopa monohydrate) 25 milligram and levodopa 100 milligram/1 each prolonged-release oral tablet Has presentation strength denominator unit False Tablet Inferred relationship Existential restriction modifier 2
Product containing precisely aspirin 300 milligram/1 each gastro-resistant oral tablet Has unit of presentation False Tablet Inferred relationship Existential restriction modifier
Product containing precisely aspirin 300 milligram/1 each gastro-resistant oral tablet Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely bupropion hydrochloride 150 milligram/1 each prolonged-release oral tablet Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely bupropion hydrochloride 150 milligram/1 each prolonged-release oral tablet Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely carbamazepine 400 milligram/1 each prolonged-release oral tablet Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely carbamazepine 400 milligram/1 each prolonged-release oral tablet Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely diclofenac sodium 25 milligram/1 each gastro-resistant oral tablet Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely diclofenac sodium 25 milligram/1 each gastro-resistant oral tablet Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely diclofenac sodium 100 milligram/1 each prolonged-release oral tablet Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely diclofenac sodium 100 milligram/1 each prolonged-release oral tablet Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely bumetanide 500 microgram and potassium chloride 573 milligram/1 each prolonged-release oral tablet Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 2
Product containing precisely bumetanide 500 microgram and potassium chloride 573 milligram/1 each prolonged-release oral tablet Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely bumetanide 500 microgram and potassium chloride 573 milligram/1 each prolonged-release oral tablet Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely calcium carbonate 1.5 gram/1 each conventional release chewable tablet Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely calcium carbonate 1.5 gram/1 each conventional release chewable tablet Has unit of presentation False Tablet Inferred relationship Existential restriction modifier
Product containing precisely bisacodyl 5 milligram/1 each gastro-resistant oral tablet Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely bisacodyl 5 milligram/1 each gastro-resistant oral tablet Has unit of presentation False Tablet Inferred relationship Existential restriction modifier
Product containing precisely calcium carbonate 2.5 gram/1 each conventional release chewable tablet Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely calcium carbonate 2.5 gram/1 each conventional release chewable tablet Has unit of presentation False Tablet Inferred relationship Existential restriction modifier
Product containing precisely calcium carbonate 1.25 gram/1 each conventional release chewable tablet Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely calcium carbonate 1.25 gram/1 each conventional release chewable tablet Has unit of presentation False Tablet Inferred relationship Existential restriction modifier
Product containing precisely calcium carbonate 1.25 gram/1 each conventional release effervescent oral tablet Has unit of presentation False Tablet Inferred relationship Existential restriction modifier
Product containing precisely dihydrocodeine tartrate 90 milligram/1 each prolonged-release oral tablet Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely dihydrocodeine tartrate 90 milligram/1 each prolonged-release oral tablet Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely diclofenac sodium 50 milligram/1 each gastro-resistant oral tablet Has unit of presentation False Tablet Inferred relationship Existential restriction modifier
Product containing precisely diclofenac sodium 50 milligram/1 each gastro-resistant oral tablet Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely dinoprostone 3 milligram/1 each conventional release vaginal tablet Has unit of presentation False Tablet Inferred relationship Existential restriction modifier
Product containing precisely dinoprostone 3 milligram/1 each conventional release vaginal tablet Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely apomorphine hydrochloride 3 milligram/1 each conventional release sublingual tablet Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely apomorphine hydrochloride 3 milligram/1 each conventional release sublingual tablet Has unit of presentation False Tablet Inferred relationship Existential restriction modifier
Product containing precisely bezafibrate 400 milligram/1 each prolonged-release oral tablet Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely bezafibrate 400 milligram/1 each prolonged-release oral tablet Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely dexbrompheniramine maleate 6 milligram and pseudoephedrine sulfate 120 milligram/1 each prolonged-release oral tablet Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely dexbrompheniramine maleate 6 milligram and pseudoephedrine sulfate 120 milligram/1 each prolonged-release oral tablet Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 2
Product containing precisely dexbrompheniramine maleate 6 milligram and pseudoephedrine sulfate 120 milligram/1 each prolonged-release oral tablet Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely carbidopa (as carbidopa monohydrate) 50 milligram and levodopa 200 milligram/1 each prolonged-release oral tablet Has presentation strength denominator unit False Tablet Inferred relationship Existential restriction modifier 2
Product containing precisely carbidopa (as carbidopa monohydrate) 50 milligram and levodopa 200 milligram/1 each prolonged-release oral tablet Has unit of presentation False Tablet Inferred relationship Existential restriction modifier
Product containing precisely carbidopa (as carbidopa monohydrate) 50 milligram and levodopa 200 milligram/1 each prolonged-release oral tablet Has presentation strength denominator unit False Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely doxazosin (as doxazosin mesilate) 8 milligram/1 each prolonged-release oral tablet (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely doxazosin (as doxazosin mesilate) 8 milligram/1 each prolonged-release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely acamprosate calcium 333 milligram/1 each gastro-resistant oral tablet Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely acamprosate calcium 333 milligram/1 each gastro-resistant oral tablet Has unit of presentation False Tablet Inferred relationship Existential restriction modifier
Product containing precisely dihydrocodeine tartrate 60 milligram/1 each prolonged-release oral tablet Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely dihydrocodeine tartrate 60 milligram/1 each prolonged-release oral tablet Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely buprenorphine (as buprenorphine hydrochloride) 400 microgram/1 each conventional release sublingual tablet Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely buprenorphine (as buprenorphine hydrochloride) 400 microgram/1 each conventional release sublingual tablet Has unit of presentation False Tablet Inferred relationship Existential restriction modifier
Product containing precisely alfuzosin hydrochloride 10 milligram/1 each prolonged-release oral tablet Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely alfuzosin hydrochloride 10 milligram/1 each prolonged-release oral tablet Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely aminophylline 225 milligram/1 each prolonged-release oral tablet Has presentation strength denominator unit False Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely aminophylline 225 milligram/1 each prolonged-release oral tablet Has unit of presentation False Tablet Inferred relationship Existential restriction modifier
Product containing precisely disopyramide (as disopyramide phosphate) 150 milligram/1 each prolonged-release oral tablet Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely disopyramide (as disopyramide phosphate) 150 milligram/1 each prolonged-release oral tablet Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely cimetidine 400 milligram/1 each conventional release effervescent oral tablet Has unit of presentation False Tablet Inferred relationship Existential restriction modifier
Product containing precisely cimetidine 400 milligram/1 each conventional release effervescent oral tablet Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely aspirin 75 milligram/1 each gastro-resistant oral tablet Has unit of presentation False Tablet Inferred relationship Existential restriction modifier
Product containing precisely aspirin 75 milligram/1 each gastro-resistant oral tablet Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely buprenorphine (as buprenorphine hydrochloride) 8 milligram/1 each conventional release sublingual tablet Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely buprenorphine (as buprenorphine hydrochloride) 8 milligram/1 each conventional release sublingual tablet Has unit of presentation False Tablet Inferred relationship Existential restriction modifier
Product containing precisely carbamazepine 100 milligram/1 each conventional release chewable tablet Has unit of presentation False Tablet Inferred relationship Existential restriction modifier
Product containing precisely carbamazepine 100 milligram/1 each conventional release chewable tablet Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely bendroflumethiazide 2.5 milligram and potassium chloride 573 milligram/1 each prolonged-release oral tablet Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely bendroflumethiazide 2.5 milligram and potassium chloride 573 milligram/1 each prolonged-release oral tablet Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely bendroflumethiazide 2.5 milligram and potassium chloride 573 milligram/1 each prolonged-release oral tablet Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 2
Product containing precisely dihydrocodeine tartrate 120 milligram/1 each prolonged-release oral tablet Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely dihydrocodeine tartrate 120 milligram/1 each prolonged-release oral tablet Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely doxazosin (as doxazosin mesilate) 4 milligram/1 each prolonged-release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely doxazosin (as doxazosin mesilate) 4 milligram/1 each prolonged-release oral tablet (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely calcium gluconate 1 gram/1 each conventional release effervescent oral tablet Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely calcium gluconate 1 gram/1 each conventional release effervescent oral tablet Has unit of presentation False Tablet Inferred relationship Existential restriction modifier
Product containing precisely diltiazem hydrochloride 60 milligram/1 each prolonged-release oral tablet Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely diltiazem hydrochloride 60 milligram/1 each prolonged-release oral tablet Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely diltiazem hydrochloride 90 milligram/1 each prolonged-release oral tablet Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely diltiazem hydrochloride 90 milligram/1 each prolonged-release oral tablet Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely bendroflumethiazide 2.5 milligram and potassium chloride 630 milligram/1 each prolonged-release oral tablet Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 2
Product containing precisely bendroflumethiazide 2.5 milligram and potassium chloride 630 milligram/1 each prolonged-release oral tablet Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely bendroflumethiazide 2.5 milligram and potassium chloride 630 milligram/1 each prolonged-release oral tablet Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely carbamazepine 200 milligram/1 each conventional release chewable tablet Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely carbamazepine 200 milligram/1 each conventional release chewable tablet Has unit of presentation False Tablet Inferred relationship Existential restriction modifier
Product containing precisely apomorphine hydrochloride 2 milligram/1 each conventional release sublingual tablet Has unit of presentation False Tablet Inferred relationship Existential restriction modifier
Product containing precisely apomorphine hydrochloride 2 milligram/1 each conventional release sublingual tablet Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely darifenacin (as darifenacin hydrobromide) 15 milligram/1 each prolonged-release oral tablet Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely darifenacin (as darifenacin hydrobromide) 15 milligram/1 each prolonged-release oral tablet Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely buprenorphine (as buprenorphine hydrochloride) 200 microgram/1 each conventional release sublingual tablet Has unit of presentation False Tablet Inferred relationship Existential restriction modifier
Product containing precisely buprenorphine (as buprenorphine hydrochloride) 200 microgram/1 each conventional release sublingual tablet Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely clomipramine hydrochloride 75 milligram/1 each prolonged-release oral tablet Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely clomipramine hydrochloride 75 milligram/1 each prolonged-release oral tablet Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely buprenorphine (as buprenorphine hydrochloride) 2 milligram/1 each conventional release sublingual tablet Has unit of presentation False Tablet Inferred relationship Existential restriction modifier
Product containing precisely buprenorphine (as buprenorphine hydrochloride) 2 milligram/1 each conventional release sublingual tablet Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1

Start Previous Page 28 of 153 Next End

This concept is not in any reference sets

Back to Start